Changes in Energy Expenditure in Response to Physical Activity in Healthy Adults (VITAL)

April 7, 2026 updated by: Medical University of Bialystok

Assessment of Changes in Energy Expanditure in Response to Short-term Physical Activity Measured by Indirect Calorymetry in Healthy Individuals

This study investigates how short, high-intensity body-weight exercises affect energy use in healthy young adults. The focus is on resting metabolic rate (RMR), total energy expenditure (TEE) and excess post-exercise oxygen consumption (EPOC), measured with a portable indirect calorimetry system (COSMED K5). Participants will be 14 volunteers, seven women and seven men aged 18 to 30 years, recruited from the academic community of the Medical University of Białystok. Each subject will first undergo basic screening, including ECG, blood pressure, and body composition. Measurements will be taken in three phases. In the resting phase, RMR will be recorded after fifteen minutes of quiet sitting. In the exercise phase, participants will perform squats, burpees, or a plank for one minute at maximum effort or sustained position while energy use is continuously monitored. In the recovery phase, EPOC will be measured immediately after exercise to capture short-term changes. Oxygen uptake, ventilation, heart rate, and oxygen saturation will be tracked throughout the session. Environmental conditions such as room temperature and humidity will be standardized, and participants will avoid caffeine, alcohol, and heavy physical activity at least 24 hours before testing. The main aim is to determine whether even one minute of exercise can meaningfully alter EPOC steady state parameters, and to compare the energy cost of different exercise types. The data will be analyzed in relation to anthropometric variables and cardiopulmonary function. Results are expected to improve understanding of short-term energy dynamics and may support more precise recommendations in pulmonary rehabilitation, cardiology, sports medicine, and nutrition. By providing reliable measurements of caloric cost in simple exercises, the study can help design safer and more effective training, rehabilitation, and weight control programs.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Poland
    • Podlaskie Voivodeship
      • Bialystok, Podlaskie Voivodeship, Poland, 15-540
        • Recruiting
        • II Departemnt of Lung Diseases, Lung Cancer, and Internal Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers aged 18 to 30 years will be recruited from the academic community of the Medical University of Białystok, primarily students affiliated with the Student Research Group at the II Department of Pulmonary Diseases, Lung Cancer and Internal Medicine. Participants must be free of chronic diseases, musculoskeletal injuries, and active infections, and must meet standard medical screening criteria before enrollment.

Description

Inclusion Criteria:

  • Age 18-30 years
  • Healthy volunteers without chronic diseases
  • Normal resting ECG (regular sinus rhythm, 60-90 bpm)
  • Normal blood pressure according to ESC guidelines
  • Ability and willingness to provide written informed consent

Exclusion Criteria:

  • Chronic diseases or musculoskeletal injury within the past 6 months
  • Use of tobacco or nicotine products within the past 6 months
  • Blood donation >20 mL (except diagnostic) within the past 6 months
  • Use of narcotics, sedatives, or dietary supplements (e.g., creatine) within the past 2 weeks
  • Active infection, fever, or acute illness at the time of study
  • Inability to comply with study instructions (dietary restrictions, abstinence from alcohol/caffeine, exercise restrictions)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Differences Between Pre- and Post-exercise Energy Expenditure Measurement
Time Frame: Baseline and immediately post-exercise (within 10-15 minutes).
Resting metabolic rate (RMR) will be measured in kcal/min using the COSMED K5 portable indirect calorimetry system. Each participant will undergo a baseline measurement after 15 minutes of seated rest. Immediately following one minute of physical activity (squats, burpees, or plank) with continuous measurement of energy expenditure, then during restitution EPOC will be measured (in lO₂ or kcal) until values stabilize. The primary outcome is the difference between post-exercise energy expenditure and baseline, reflecting the acute impact of short-duration, high-intensity activity on energy metabolism in healthy young adults.
Baseline and immediately post-exercise (within 10-15 minutes).

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Total Energy Expenditure (TEE) During Exercise
Time Frame: From the beginning to the end of performing the exercise (1 minute).
Resting metabolic rate (RMR) will be measured in kcal/min using the COSMED K5 portable indirect calorimetry system. Each participant will undergo a baseline measurement after 15 minutes of seated rest. Immediately following one minute of physical activity (squats, burpees, or plank) with continuous measurement of energy expenditure, then during restitution EPOC will be measured (in lO₂ or kcal) until values stabilize. The secondary outcome is a measure of energy expenditure during one minute of high-intensity activity in healthy young adults.
From the beginning to the end of performing the exercise (1 minute).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Medical University of Bialystok

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
University Teaching Hospital, Bialystok

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 1, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 7, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 7, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 14, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 14, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 7, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • APK.002.256.2025

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings